Algernon Pharmaceuticals Inc (AGNPF)

[medchem]

While it's a good question, it's a bit of a moot point because they are telling you they are going to give you something better than simply announcing trial "complete enrollment", instead their going to actually give you DATA. This is truly make or break. I mean if these guys have good data, this stock share price is going to sky rocket out of control. If not, well we move forward to IPF and chronic cough. The reason I have faith, is because no company would ever release bad data early... AND ... no company would release early data if they were unsure ... there is scientific reasoning for this

1) Release the good data early = secure big pharma funding for phase 3 now, rather than when phase 3 needs to start (that would cause delays)

2) if you release early data with less patients, you have less trial "power" when looking for positive signal... you could easily increase trial "power" by waiting for more patients to be enrolled which would increase your likelihood of finding positive signal... but clearly they don't care and are releasing data for less patients which is highly suggestive they have big signal